Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?

about

Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma.Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases?

P2860

Q39430849-2881DEFB-FF64-4628-9975-70336701C159 Q57169367-A02BE429-7D85-461E-ACB5-DE3B15890C30

P2860

Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?

Item

http://www.wikidata.org/entity/Q38905077

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Preoperative FOLFIRINOX for bo ...... he modern era of chemotherapy?

@en

type

Item

label

Preoperative FOLFIRINOX for bo ...... he modern era of chemotherapy?

@en

prefLabel

Preoperative FOLFIRINOX for bo ...... he modern era of chemotherapy?

@en

P1476

Preoperative FOLFIRINOX for bo ...... he modern era of chemotherapy?

@en

P2093

Andrew H Ko

http://www.w3.org/2001/XMLSchema#string

Carlos U Corvera

http://www.w3.org/2001/XMLSchema#string

Eric K Nakakura

http://www.w3.org/2001/XMLSchema#string

Grace E Kim

http://www.w3.org/2001/XMLSchema#string

Hobart W Harris

http://www.w3.org/2001/XMLSchema#string

Kimberly S Kirkwood

http://www.w3.org/2001/XMLSchema#string

Margaret A Tempero

http://www.w3.org/2001/XMLSchema#string

Ryutaro Hirose

http://www.w3.org/2001/XMLSchema#string

Sunhee S Kim

http://www.w3.org/2001/XMLSchema#string

Zhen J Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

Estimating the mean and variance from the median, range, and the size of a sample

Cancer statistics, 2016

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.

Neoadjuvant modified (m) FOLFIRINOX for locally advanced unresectable (LAPC) and borderline resectable (BRPC) adenocarcinoma of the pancreas.

Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer.

Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer

Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?

P304

587-596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.24375

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27444658

http://www.w3.org/2001/XMLSchema#string

Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?

about

P2860

P2860

Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698